Rock - Some good points, but all factored in...this stock is oversold. The Palmaz patent expires in November of this year (did you know that?) - even looking at the worse case, which the weak kneed investors are doing right now, the damages will be moderate.
I'm glad you are so bullish. So were all the idiots who bought this stock at $45. I can guarantee that BSX has not "set aside" the kind of $ it will take to pay the NIR damages, the legal bills, the triple damages for a willful infringement loss in June on Taxus sales. This alone could be = to 3-4 years of gross earnings. Just because you and the other longs deny the impact, and brush this off does not take away the hurt of the massive $s at stake. The market also has certainly not figured in the Taxus and Medinol losses. How could they. BSX keeps blowing smoke and BS about how they will "never pay a dime (as per Mr. "Honest Abe" Tobin)." That losing hand is about to be called!
<<<....NIR damages, the legal bills, the triple damages for a willful infringement loss in June on Taxus sales>>>
Rock - the June judgement is stricly NIR, so it will be minimal in the scheme of things. NIR was small potatoes. The taxus platform hasn't gotten past the preliminaries yet - so your off base with your comments. The stock will be higher in 6 months, that's the only gaurantee.